| Medical and Health Sciences | 2021-2025 | 801 | IT 53 | 99.82 |
| Ophthalmology | Lifetime | 35 | IT 1 | 99.80 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 228 | IT 3 | 99.42 |
| Ophthalmology | 2021-2025 | 8 | IT 1 | 99.81 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 46 | IT 3 | 99.20 |
| Molecular Biology | 2021-2025 | 932 | IT 22 | 94.73 |
| Clinical Neurology | 2021-2025 | 537 | IT 38 | 78.47 |
| Immunology | 2021-2025 | 889 | IT 32 | 66.55 |
| Retinal Diseases and Treatments | Lifetime | 57 | IT 1 | 99.68 |
| Retinal and Optic Conditions | Lifetime | 31 | IT 1 | 99.70 |
| Glaucoma and retinal disorders | Lifetime | 76 | IT 1 | 99.65 |
| Retinal Imaging and Analysis | Lifetime | 45 | IT 1 | 99.64 |
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 53 | IT 1 | 99.36 |
| Retinal and Macular Surgery | Lifetime | 45 | IT 1 | 99.33 |
| Retinal Development and Disorders | Lifetime | 265 | IT 3 | 98.36 |
| Intraocular Surgery and Lenses | Lifetime | 288 | IT 4 | 98.48 |
| Ocular Oncology and Treatments | Lifetime | 143 | IT 3 | 97.18 |
| Retinopathy of Prematurity Studies | Lifetime | 176 | IT 9 | 95.60 |
| Optical Coherence Tomography Applications | Lifetime | 559 | IT 17 | 95.01 |
| Dermatological and Skeletal Disorders | Lifetime | 306 | IT 19 | 94.47 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 734 | IT 22 | 93.18 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 548 | IT 43 | 93.99 |
| Neurological Complications and Syndromes | Lifetime | 564 | IT 32 | 92.00 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 906 | IT 72 | 91.80 |
| Drug-Induced Ocular Toxicity | Lifetime | 161 | IT 5 | 90.44 |
| Ophthalmology and Visual Health Research | Lifetime | 660 | IT 3 | 78.10 |
| Retinal Diseases and Treatments | 2021-2025 | 12 | IT 1 | 99.64 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 5 | IT 2 | 98.88 |
| Retinal Development and Disorders | 2021-2025 | 7 | IT 1 | 99.34 |
| Retinal and Optic Conditions | 2021-2025 | 12 | IT 1 | 99.43 |
| Glaucoma and retinal disorders | 2021-2025 | 32 | IT 1 | 99.31 |
| Retinal Imaging and Analysis | 2021-2025 | 27 | IT 1 | 99.25 |
| Retinal and Macular Surgery | 2021-2025 | 10 | IT 4 | 98.64 |
| Intraocular Surgery and Lenses | 2021-2025 | 43 | IT 7 | 98.05 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 353 | IT 17 | 85.98 |
| Corneal surgery and disorders | 2021-2025 | 693 | IT 40 | 88.98 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 301 | IT 21 | 85.37 |
| Vascular Malformations Diagnosis and Treatment | 2021-2025 | 645 | IT 25 | 82.93 |
| Dermatological and Skeletal Disorders | 2021-2025 | 130 | IT 26 | 78.64 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 37 | IT 3 | 74.16 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 893 | IT 18 | 81.52 |
| Optical Coherence Tomography Applications | 2021-2025 | 753 | IT 16 | 78.84 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 829 | IT 37 | 69.01 |
| Retinopathy of Prematurity Studies | 2021-2025 | 626 | IT 14 | 57.80 |
